LNTH (Lantheus Holdings) Moat Score: 5/10 (As of Jul. 02, 2026)


LNTH Lantheus Holdings Inc LNTH
82 GF Score
Price $109.48
GF Value $90.85
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Lantheus Holdings Moat Score?

Lantheus Holdings LNTH +0.50% 82 Moat Score is 5 as of Jul. 02, 2026. GuruFocus rates LNTH with a GF Score™ of 82/100 and a GF Value™ of $90.85 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,032 Drug Manufacturers companies, Lantheus Holdings ranks better than 94.67% on this metric.

Lantheus Holdings has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Lantheus Holdings has Narrow Moat: Lantheus Holdings Inc has a solid narrow moat with valuable intellectual property and strong R&D capabilities. However, it lacks the scale and regulatory barriers necessary for a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Lantheus Holdings might have Narrow Moat - Solid narrow moat.

Lantheus Holdings  (NAS:LNTH) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Lantheus Holdings Moat Score Related Terms

LNTH vs LQDA, HIMS, AMRX: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lantheus Holdings Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where Lantheus Holdings's Moat Score falls into.


LNTH
82GF Score
Lantheus Holdings Inc LNTH
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Lantheus Holdings (LNTH) has a Moat Score of 5 as of Jul. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Lantheus Holdings ranks #55 out of 1032 companies in the Drug Manufacturers industry, placing it in the top 5.3%.
Is Lantheus Holdings' Moat Score too high?
Lantheus Holdings' current Moat Score is 5. Based on the distribution chart, Lantheus Holdings ranks #55 out of 1032 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Lantheus Holdings has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lantheus Holdings' Moat Score compare to LQDA and HIMS?
According to the Drug Manufacturers industry distribution chart, Lantheus Holdings ranks #55 out of 1032 companies for Moat Score. This places Lantheus Holdings in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Lantheus Holdings's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lantheus Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lantheus Holdings (LNTH) is currently considered Modestly Overvalued. The stock's GF Value™ is $90.85, compared to a current price of $109.48 — trading 20.5% above its estimated fair value. The current Moat Score is 5. Lantheus Holdings' overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Lantheus Holdings (LNTH), the current Moat Score is 5 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lantheus Holdings (LNTH) Overvalued in 2026?

Based on GuruFocus' analysis, Lantheus Holdings stock appears to be overvalued. The current stock price of $109.48 is trading 20.5% above its estimated GF Value™ of $90.85. GuruFocus considers Lantheus Holdings to be Modestly Overvalued.

Key valuation signals for LNTH:

  • Moat Score: 5
  • GF Value™: $90.85 vs. price of $109.48 (20.5% above fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the LNTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lantheus Holdings Business Description

Other Exchanges 1LNTH:Italy0L8:Germany
Address 201 Burlington Road, South Building, Bedford, MA, USA, 01730
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
82GF Score

Get the complete analysis for LNTH

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$109.48
Price
$90.85
GF Value